US Stock MarketDetailed Quotes

GTBP GT Biopharma

Watchlist
  • 2.8600
  • -0.1850-6.08%
Close Nov 27 16:00 ET
6.39MMarket Cap-383P/E (TTM)

GT Biopharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-39.36%-2.74M
-82.74%-3.54M
-43.26%-4.16M
41.83%-8.85M
52.37%-2.05M
32.69%-1.96M
30.55%-1.94M
44.28%-2.91M
2.49%-15.22M
-16.01%-4.3M
Net income from continuing operations
-41.18%-3.41M
-86.24%-3.71M
-898.24%-2.27M
63.62%-7.6M
46.96%-2.96M
64.89%-2.42M
33.13%-1.99M
95.83%-227K
64.00%-20.88M
69.02%-5.58M
Operating gains losses
80.41%-95K
91.65%-117K
80.97%-658K
-3,462.67%-5.34M
98.55%-1K
-736.21%-485K
-27,920.00%-1.4M
-19,105.56%-3.46M
28.91%-150K
58.93%-69K
Other non cash items
--0
3.85%27K
4.00%26K
-13.85%112K
--34K
--27K
-93.33%26K
-97.13%25K
-81.94%130K
----
Change In working capital
108.42%767K
-85.91%147K
-3,322.50%-1.37M
191.75%1.83M
-85.67%454K
110.83%368K
257.79%1.04M
96.36%-40K
-125.05%-1.99M
-50.75%3.17M
-Change in prepaid assets
-2,200.00%-231K
654.55%61K
-62.50%6K
-116.54%-21K
-208.82%-37K
-91.79%11K
-104.76%-11K
105.88%16K
-27.01%127K
132.38%34K
-Change in payables and accrued expense
159.22%998K
-89.27%116K
-4,544.83%-1.35M
196.65%1.96M
-83.74%525K
110.91%385K
221.32%1.08M
96.54%-29K
-126.14%-2.03M
-50.63%3.23M
-Change in other current liabilities
--0
-11.11%-30K
-3.70%-28K
-34.88%-116K
-41.67%-34K
-12.00%-28K
-12.50%-27K
-107.69%-27K
---86K
---24K
Cash from discontinued investing activities
Operating cash flow
-39.36%-2.74M
-82.74%-3.54M
-43.26%-4.16M
41.83%-8.85M
52.37%-2.05M
32.69%-1.96M
30.55%-1.94M
44.28%-2.91M
2.49%-15.22M
-16.01%-4.3M
Investing cash flow
Cash flow from continuing investing activities
-100.05%-1K
195.78%7.86M
172.03%5.03M
-116.54%-2.01M
-93.63%478K
7,280.00%1.85M
145.79%2.66M
-297.82%-6.99M
152.71%12.15M
150.95%7.51M
Net investment purchase and sale
-100.05%-1K
195.78%7.86M
172.03%5.03M
-116.54%-2.01M
-93.63%478K
7,280.00%1.85M
145.79%2.66M
-297.82%-6.99M
152.71%12.15M
150.95%7.51M
Cash from discontinued investing activities
Investing cash flow
-100.05%-1K
195.78%7.86M
172.03%5.03M
-116.54%-2.01M
-93.63%478K
7,280.00%1.85M
145.79%2.66M
-297.82%-6.99M
152.71%12.15M
150.95%7.51M
Financing cash flow
Cash flow from continuing financing activities
0
2.98M
0
2,898.21%6.27M
0
0
0
6.27M
-100.53%-224K
-1K
Net common stock issuance
--0
--2.98M
--0
2,898.21%6.27M
--0
--0
--0
--6.27M
-100.91%-224K
---1K
Cash from discontinued financing activities
Financing cash flow
--0
--2.98M
--0
2,898.21%6.27M
--0
--0
--0
--6.27M
-100.53%-224K
---1K
Net cash flow
Beginning cash position
234.26%9.25M
-4.65%1.95M
-80.98%1.08M
-36.75%5.67M
7.42%2.65M
-48.36%2.77M
-71.93%2.05M
-36.75%5.67M
69.30%8.97M
-74.54%2.47M
Current changes in cash
-2,200.84%-2.74M
910.94%7.3M
124.01%871K
-39.35%-4.59M
-148.92%-1.57M
95.89%-119K
137.45%722K
-115.64%-3.63M
-189.78%-3.3M
549.16%3.21M
End cash Position
145.88%6.51M
234.26%9.25M
-4.65%1.95M
-80.98%1.08M
-80.98%1.08M
7.42%2.65M
-48.36%2.77M
-71.93%2.05M
-36.75%5.67M
-36.75%5.67M
Free cash flow
-39.36%-2.74M
-82.74%-3.54M
-43.26%-4.16M
41.83%-8.85M
52.37%-2.05M
32.69%-1.96M
30.55%-1.94M
44.28%-2.91M
2.49%-15.22M
-16.01%-4.3M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -39.36%-2.74M-82.74%-3.54M-43.26%-4.16M41.83%-8.85M52.37%-2.05M32.69%-1.96M30.55%-1.94M44.28%-2.91M2.49%-15.22M-16.01%-4.3M
Net income from continuing operations -41.18%-3.41M-86.24%-3.71M-898.24%-2.27M63.62%-7.6M46.96%-2.96M64.89%-2.42M33.13%-1.99M95.83%-227K64.00%-20.88M69.02%-5.58M
Operating gains losses 80.41%-95K91.65%-117K80.97%-658K-3,462.67%-5.34M98.55%-1K-736.21%-485K-27,920.00%-1.4M-19,105.56%-3.46M28.91%-150K58.93%-69K
Other non cash items --03.85%27K4.00%26K-13.85%112K--34K--27K-93.33%26K-97.13%25K-81.94%130K----
Change In working capital 108.42%767K-85.91%147K-3,322.50%-1.37M191.75%1.83M-85.67%454K110.83%368K257.79%1.04M96.36%-40K-125.05%-1.99M-50.75%3.17M
-Change in prepaid assets -2,200.00%-231K654.55%61K-62.50%6K-116.54%-21K-208.82%-37K-91.79%11K-104.76%-11K105.88%16K-27.01%127K132.38%34K
-Change in payables and accrued expense 159.22%998K-89.27%116K-4,544.83%-1.35M196.65%1.96M-83.74%525K110.91%385K221.32%1.08M96.54%-29K-126.14%-2.03M-50.63%3.23M
-Change in other current liabilities --0-11.11%-30K-3.70%-28K-34.88%-116K-41.67%-34K-12.00%-28K-12.50%-27K-107.69%-27K---86K---24K
Cash from discontinued investing activities
Operating cash flow -39.36%-2.74M-82.74%-3.54M-43.26%-4.16M41.83%-8.85M52.37%-2.05M32.69%-1.96M30.55%-1.94M44.28%-2.91M2.49%-15.22M-16.01%-4.3M
Investing cash flow
Cash flow from continuing investing activities -100.05%-1K195.78%7.86M172.03%5.03M-116.54%-2.01M-93.63%478K7,280.00%1.85M145.79%2.66M-297.82%-6.99M152.71%12.15M150.95%7.51M
Net investment purchase and sale -100.05%-1K195.78%7.86M172.03%5.03M-116.54%-2.01M-93.63%478K7,280.00%1.85M145.79%2.66M-297.82%-6.99M152.71%12.15M150.95%7.51M
Cash from discontinued investing activities
Investing cash flow -100.05%-1K195.78%7.86M172.03%5.03M-116.54%-2.01M-93.63%478K7,280.00%1.85M145.79%2.66M-297.82%-6.99M152.71%12.15M150.95%7.51M
Financing cash flow
Cash flow from continuing financing activities 02.98M02,898.21%6.27M0006.27M-100.53%-224K-1K
Net common stock issuance --0--2.98M--02,898.21%6.27M--0--0--0--6.27M-100.91%-224K---1K
Cash from discontinued financing activities
Financing cash flow --0--2.98M--02,898.21%6.27M--0--0--0--6.27M-100.53%-224K---1K
Net cash flow
Beginning cash position 234.26%9.25M-4.65%1.95M-80.98%1.08M-36.75%5.67M7.42%2.65M-48.36%2.77M-71.93%2.05M-36.75%5.67M69.30%8.97M-74.54%2.47M
Current changes in cash -2,200.84%-2.74M910.94%7.3M124.01%871K-39.35%-4.59M-148.92%-1.57M95.89%-119K137.45%722K-115.64%-3.63M-189.78%-3.3M549.16%3.21M
End cash Position 145.88%6.51M234.26%9.25M-4.65%1.95M-80.98%1.08M-80.98%1.08M7.42%2.65M-48.36%2.77M-71.93%2.05M-36.75%5.67M-36.75%5.67M
Free cash flow -39.36%-2.74M-82.74%-3.54M-43.26%-4.16M41.83%-8.85M52.37%-2.05M32.69%-1.96M30.55%-1.94M44.28%-2.91M2.49%-15.22M-16.01%-4.3M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data